Discontinued — last reported Q4 '25

Tax

Tax Reconciliation: Change in Valuation Allowance

Insmed Tax Reconciliation: Change in Valuation Allowance remained flat by 0.0% to -5.3% in Q4 2025 compared to the prior quarter. Year-over-year, this metric declined by 4.4%, from -5.1% to -5.3%. Over 4 years (FY 2021 to FY 2025), Tax Reconciliation: Change in Valuation Allowance shows an upward trend with a -5.8% CAGR.

Analysis

StatementIncome Statement
SectionTax
CategoryProfitability
SignalContext dependent
VolatilityModerate
First reportedQ1 2015
Last reportedQ4 2025

How to read this metric

A negative impact on the rate reconciliation suggests a reduction in the allowance, which can improve net income.

Detailed definition

This metric measures the specific impact of adjustments to the valuation allowance for deferred tax assets on the compan...

Peer comparison

Commonly disclosed in the effective tax rate reconciliation table of 10-K filings.

Metric ID: cat_tax_reconciliation_valuation_allowance_change

Historical Data

5 years
 FY'21FY'22FY'23FY'24FY'25
Value-27%-22%-17.5%-20.4%-21.3%
YoY Change+18.5%+20.5%-16.6%-4.4%
Range-27%-17.5%
CAGR-5.8%
Avg YoY Growth+4.5%
Median YoY Growth+7.1%
Current Streak2 years decline

Frequently Asked Questions

What is Insmed's tax reconciliation: change in valuation allowance?
Insmed (INSM) reported tax reconciliation: change in valuation allowance of -5.3% in Q4 2025.
How has Insmed's tax reconciliation: change in valuation allowance changed year-over-year?
Insmed's tax reconciliation: change in valuation allowance decreased by 4.4% year-over-year, from -5.1% to -5.3%.
What is the long-term trend for Insmed's tax reconciliation: change in valuation allowance?
Over 4 years (2021 to 2025), Insmed's tax reconciliation: change in valuation allowance has grown at a -5.8% compound annual growth rate (CAGR), from -27.0% to -21.3%.
What does tax reconciliation: change in valuation allowance mean?
The impact on the effective tax rate caused by changes in the valuation allowance for deferred tax assets.